Three pharmaceutical firms to jointly develop new antiviral drugs

Published: 2002-04-01 06:56:00

Updated: 2002-04-01 06:56:00

Pacific Pharm, Pacific Co. and Entopharm, a bioventure firm, established their strategic alliances on March 27 for the joint development of alloferon, a lead compound discovered by Entopharm, for the treatment of hepatitis B and C. Following the commercialization of alloferon, Pacific Pharm is to...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK